The ovarian insulin-like growth factors, a local amplification mechanism for steroidogenesis and hormone action. 1991

J M Hammond, and J S Mondschein, and S E Samaras, and S F Canning
Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.

The importance of the ovarian insulin-like growth factors (IGFs) has been suggested by data from numerous laboratories and several approaches in the last several years. In the aggregate, these data indicate that this system could function as an important local amplification mechanism for steroidogenesis and gonadotropin action. Studies supporting this hypothesis have described several interacting components of this autocrine/paracrine system. First, the several types of ovarian cells possess an IGF-response system, which includes receptors for IGFs and an effective intracellular transduction system. The IGFs can promote growth and/or differentiation of ovarian cells, and their predominant actions depend on the nature of the cells and the presence of additional modulating factors. The biochemical events leading to enhanced steroidogenesis are now understood in considerable detail and include induction of several steps in the cAMP-dependent steroidogenic cascade. The second component of the ovarian IGF system comprises hormone-responsive local production of IGFs. Both IGF-I and IGF-II may be secreted; gonadotropins, gonadal steroids and locally produced growth factors can regulate the IGF system at this level. Finally, ovarian cells secrete a heterogeneous and complex family of IGF-binding proteins (IGFBPs). These proteins can impact on multiple ovarian functions in a manner which is generally opposite to that of the IGFs themselves. As is the case for the IGFs, the secretion of these proteins by ovarian cells is regulated by gonadotropins and locally produced ovarian factors. Collectively, these several components provide an integrated, synergistically cooperative local network to promote gonadotropin-dependent growth and differentiation in the ovary.

UI MeSH Term Description Entries
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D005260 Female Females
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013002 Somatomedins Insulin-like polypeptides made by the liver and some fibroblasts and released into the blood when stimulated by SOMATOTROPIN. They cause sulfate incorporation into collagen, RNA, and DNA synthesis, which are prerequisites to cell division and growth of the organism. Sulfation Factor,Somatomedin,Factor, Sulfation
D013256 Steroids A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed) Steroid,Catatoxic Steroids,Steroids, Catatoxic

Related Publications

J M Hammond, and J S Mondschein, and S E Samaras, and S F Canning
September 1992, Annals of internal medicine,
J M Hammond, and J S Mondschein, and S E Samaras, and S F Canning
September 1990, Ugeskrift for laeger,
J M Hammond, and J S Mondschein, and S E Samaras, and S F Canning
January 1994, Bulletin et memoires de l'Academie royale de medecine de Belgique,
J M Hammond, and J S Mondschein, and S E Samaras, and S F Canning
March 1993, General and comparative endocrinology,
J M Hammond, and J S Mondschein, and S E Samaras, and S F Canning
August 1953, British medical journal,
J M Hammond, and J S Mondschein, and S E Samaras, and S F Canning
May 1972, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J M Hammond, and J S Mondschein, and S E Samaras, and S F Canning
July 1989, European journal of pharmacology,
J M Hammond, and J S Mondschein, and S E Samaras, and S F Canning
January 1970, Advances in metabolic disorders,
J M Hammond, and J S Mondschein, and S E Samaras, and S F Canning
August 2008, Endocrine reviews,
J M Hammond, and J S Mondschein, and S E Samaras, and S F Canning
January 2005, Medicinski pregled,
Copied contents to your clipboard!